The New York Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-dark"]
Menu
Business

FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV

Read Time:5 Second

RSV is the leading cause of hospitalization among children less than a year old, according to scientists.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
0 0
Previous post Brett Arends’s ROI: $100,000 worth of investments for $85,000? In this market?
Next post : FDA approves Sanofi and AstraZeneca infant RSV vaccine

More Stories